Oncolytic adenovirus H101 ameliorate the efficacy of anti-PD-1 monotherapy in colorectal cancer.

Cancer medicine(2022)

Cited 6|Views17
No score
Abstract
The present study elucidates that Onco promotes intratumor T cell infiltration and improves anti-PD-1 immunotherapy, thereby providing a potent combinatorial therapeutic strategy for CRC.
More
Translated text
Key words
CD8+ T cells,anti-PD-1 therapy,colorectal cancer,immunotherapy,oncolytic adenovirus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined